Whitehawk Therapeutics (WHWK) Divestments (2025)

Whitehawk Therapeutics' (WHWK) quarterly Divestments came in at -$70000.0 in Q3 2025, down 100.07% on a QoQ basis from $101.4 million in Q1 2025.

Whitehawk Therapeutics (WHWK) Divestments (2025) Analysis & Trends

Whitehawk Therapeutics (WHWK) has 1 years of Divestments data on file, last reported at -$70000.0 in Q3 2025.

  • On a quarterly basis, Divestments changed N/A year-over-year to -$70000.0 in Q3 2025; TTM through Mar 2026 was -$70000.0, a 100.07% decrease from a year earlier, with the FY2025 full-year figure at $101.3 million, changed N/A from the prior year.
  • Divestments for Q3 2025 stood at -$70000.0, down from $101.4 million in the prior quarter.
  • Over the last five years, Divestments for WHWK reached as high as $101.4 million in Q1 2025 and fell as low as -$70000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -32.58 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Whitehawk Therapeutics 34.18 Mn 34.18 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -70,000.00
Mar 31, 2025 101.36 Mn